Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Synthetic double-stranded oligonucleotides for specific inhibition of gene expression

Synthetic double-stranded oligonucleotides for specific inhibition of gene expression

US Patent 8772469 · Granted Jul 8, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Soluble guanylate cyclase activators for treating portal hypertension2025
Alkoxy pyrazoles as soluble guanylate cyclase activators2023
Unit for a mechanical connecting device for medical purposes, particularly for p2023
Container for medical use2022
Apparatus for connecting a tube connector to a fitting and to fasten or unfasten2022
Medical storage container2021
Multimeric oligonucleotide compounds having non-nucleotide based cleavable linke2020
Multimeric oligonucleotide compounds2020
Modified TGF-beta oligonucleotides2020
CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immun2019
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treat2018
Multimetric oligonucleotide compounds2018